anna caldwell, Author at European Medical Journal - Page 6 of 16

Heart Failure Predicted Up to Five Years Early

In this study of 72,751 adults without prior heart failure or myocardial infarction, researchers used automated imaging analysis to extract over 1,600 radiomic features from epicardial fat captured during coronary CT angiography.

Complete Tumour Regression in Novel Brain Cancer Treatment Model

A new glioblastoma treatment showed tumour elimination and durable protection in a preclinical model. Discover what this means for future therapies. Read more.

England Relaunches Women’s Health Strategy Amid “Medical Misogyny”

The UK Government has relaunched the Women’s Health Strategy for England on 14th April 2026, following select committee findings of “medical misogyny” in the NHS.

Tuberculosis Vaccine Trial Shows Limited Overall Protection

A phase 3 trial of two tuberculosis vaccines shows limited overall protection but meaningful efficacy against extrapulmonary disease in selected groups.

England’s Advances Towards Hepatitis C Elimination Targets

England reports progress towards hepatitis C elimination as prevalence falls, with diagnosis gaps and harm reduction challenges remaining.

High-Resolution MRI Improves Brain Imaging Clarity

5.0 T SWI improves brain imaging clarity compared with 3.0 T, enhancing visualisation of cerebral veins and deep grey matter structures in healthy adults.

Music Matches Benzodiazepines in Reducing Perioperative Anxiety

Researchers have calculated the number needed to treat for music intervention in perioperative anxiety and the result is somewhat comparable to that of benzodiazepines.

Novo partners with OpenAI to boost drug development

Novo Nordisk announced on 14 April 2026 a strategic partnership with OpenAI to boost drug development by streamlining manufacturing, supply chains and distribution.

At Least 21,000 NHS Posts to be Axed Amid Funding Crisis

A new FOI report from Unison has revealed that at least 21,000 NHS roles across England are set to be cut by 2028, amid a mounting financial crisis.

Biopharma company joins lawsuit over CMS hemp pilot

MMJ International Holdings has joined plaintiffs taking legal action against the CMS.